XML 14 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 157,496 $ 176,479
Accounts receivable, net 35,959 2,719
Inventory 24,534 241
Prepaid expenses and other current assets 8,730 5,666
Total current assets 226,719 185,105
Property, plant and equipment, net 10,704 8,298
Operating lease right-of-use assets, net 4,014 4,187
Indemnification asset, related party 8,294 7,460
Contract acquisition costs, net 6,901 7,286
Intangible asset, net 2,988 3,156
Goodwill 3,903 3,903
Restricted cash 3,504  
Other assets 8,954 10,918
Total assets 275,981 230,313
Current liabilities:    
Accounts payable 6,019 4,689
Accrued expenses and other current liabilities 40,444 18,659
Long-term debt, current 56,051 18,016
Operating and finance lease liabilities, current 428 417
Total current liabilities 102,942 41,781
Litigation finance payable 8,284 7,300
Long-term debt, noncurrent 136,446 95,268
Operating and finance lease liabilities, noncurrent 6,257 6,586
Total liabilities 253,929 150,935
Commitments and contingencies (Note 12)
Stockholders' equity:    
Preferred stock - 10,000,000 shares authorized, none outstanding 0 0
Common stock - $0.001 par value, 115,000,000 shares authorized as of September 30, 2025 and December 31, 2024, respectively, 86,819,212 and 84,683,063 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively 87 85
Additional paid-in capital 662,833 636,682
Accumulated deficit (640,868) (557,389)
Total stockholders' equity 22,052 79,378
Total liabilities and stockholders' equity $ 275,981 $ 230,313